Related Experiment Videos
Defective regulation of chemotaxis in cirrhosis
Insights
Cirrhotic patients exhibit a severe leukotactic defect due to elevated chemotactic factor inactivator (CFI) levels. This impairs immune cell movement, potentially explaining increased infection susceptibility in liver cirrhosis.
Area of Science:
- Immunology
- Hepatology
- Clinical Medicine
Background:
- Cirrhosis is associated with immune dysfunction.
- Leukotaxis, or immune cell movement, is crucial for host defense.
- Defects in leukotaxis can increase infection risk.
Purpose of the Study:
- To investigate the cause of leukotactic defects in cirrhotic patients.
- To identify specific factors contributing to impaired immune cell function in liver cirrhosis.
Main Methods:
- Serum analysis of cirrhotic patients and healthy controls.
- Assay of chemotactic factor inactivator (CFI) levels and activity.
- Evaluation of chemotactic activity generation in response to complement activation.
Main Results:
- Cirrhotic patients possess significantly higher levels of CFI in their serum.
- CFI irreversibly inactivates key chemotactic factors.
- Impaired generation of chemotactic activity was observed in cirrhotic serum.
- Minor physicochemical differences noted between CFI from cirrhotic and normal serum.
Conclusions:
- Elevated CFI levels are responsible for the leukotactic defect in cirrhosis.
- This defect likely contributes to increased bacterial infection susceptibility in cirrhotic patients.
- The findings shed light on impaired cellular immunity in liver disease.
Abstract:
The presence of a severe leukotactic defect in cirrhotic patients has been confirmed. This defect is due to the presence of abnormally high levels of the chemotactic factor inactivator (CFI) in serums of patients with hepatic cirrhosis. This inactivator inhibits each of three different chemotactic factors tested and does so in an irreversible manner. As would be predicted by these results, generation of chemotactic activity in cirrhotic serums by a complement-activating agent is markedly impaired. Physicochemical features of CFI in cirrhotic serum differ slightly from that found in normal human serum. These results indicate the nature of the chemotactic defect in cirrhotic patients and may explain the increased susceptibility of these patients to bacterial infections and some of their reported defected in expression of cellular immunity.